Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.

Descripción del Articulo

The authors have studied the contraceptive effect of 17-Alpha Hydroxi-19-Norprogesterona Capronate (SN - 582) in 21 normal women; the effect is present during 6-8 weeks after the inyection of 200 mg. During this time menstrual irregularities as spotting and amenorrhea were observed, but their incide...

Descripción completa

Detalles Bibliográficos
Autores: Hurtado, Hilario, Kesseru, Esteban, Larrañaga, Alfredo
Formato: artículo
Fecha de Publicación:2015
Institución:Sociedad Peruana de Obstetricia y Ginecología
Repositorio:Revista Peruana de Ginecología y Obstetricia
Lenguaje:español
OAI Identifier:oai:ginecologiayobstetricia.pe:article/1457
Enlace del recurso:https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/1457
Nivel de acceso:acceso abierto
id REVSPOG_20f32c7728b940bdf567003cbdeb7798
oai_identifier_str oai:ginecologiayobstetricia.pe:article/1457
network_acronym_str REVSPOG
network_name_str Revista Peruana de Ginecología y Obstetricia
repository_id_str .
spelling Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.Empleo del capronato de 17-hidroxi-19-norprogesterona como anticonceptivo inyectable de depósitoHurtado, HilarioKesseru, EstebanLarrañaga, AlfredoThe authors have studied the contraceptive effect of 17-Alpha Hydroxi-19-Norprogesterona Capronate (SN - 582) in 21 normal women; the effect is present during 6-8 weeks after the inyection of 200 mg. During this time menstrual irregularities as spotting and amenorrhea were observed, but their incidence was lower than those produced by the norethisterone enanthate (SN - 393).Los autores han estudiado el efecto anticonceptivo de 17-alfa hidroxi-19-Norprogesterona capronato (SN - 582) en 21 mujeres normales; el efecto está presente durante 6-8 semanas después de la Inyección de 200 mg. Durante este tiempo se observaron irregularidades menstruales como la localización y la amenorrea, pero su incidencia fue menor que las producidas por el enantato de noretisterona (SN - 393).Sociedad Peruana de Obstetricia y Ginecología2015-07-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/145710.31403/rpgo.v14i1457The Peruvian Journal of Gynecology and Obstetrics ; Vol. 14 No. 2 (1968); 223-233Revista Peruana de Ginecología y Obstetricia; Vol. 14 Núm. 2 (1968); 223-2332304-51322304-5124reponame:Revista Peruana de Ginecología y Obstetriciainstname:Sociedad Peruana de Obstetricia y Ginecologíainstacron:SPOGspahttps://ginecologiayobstetricia.pe/index.php/RPGO/article/view/1457/1409info:eu-repo/semantics/openAccessoai:ginecologiayobstetricia.pe:article/14572026-01-12T19:36:57Z
dc.title.none.fl_str_mv Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
Empleo del capronato de 17-hidroxi-19-norprogesterona como anticonceptivo inyectable de depósito
title Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
spellingShingle Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
Hurtado, Hilario
title_short Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
title_full Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
title_fullStr Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
title_full_unstemmed Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
title_sort Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
dc.creator.none.fl_str_mv Hurtado, Hilario
Kesseru, Esteban
Larrañaga, Alfredo
author Hurtado, Hilario
author_facet Hurtado, Hilario
Kesseru, Esteban
Larrañaga, Alfredo
author_role author
author2 Kesseru, Esteban
Larrañaga, Alfredo
author2_role author
author
description The authors have studied the contraceptive effect of 17-Alpha Hydroxi-19-Norprogesterona Capronate (SN - 582) in 21 normal women; the effect is present during 6-8 weeks after the inyection of 200 mg. During this time menstrual irregularities as spotting and amenorrhea were observed, but their incidence was lower than those produced by the norethisterone enanthate (SN - 393).
publishDate 2015
dc.date.none.fl_str_mv 2015-07-20
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/1457
10.31403/rpgo.v14i1457
url https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/1457
identifier_str_mv 10.31403/rpgo.v14i1457
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://ginecologiayobstetricia.pe/index.php/RPGO/article/view/1457/1409
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
publisher.none.fl_str_mv Sociedad Peruana de Obstetricia y Ginecología
dc.source.none.fl_str_mv The Peruvian Journal of Gynecology and Obstetrics ; Vol. 14 No. 2 (1968); 223-233
Revista Peruana de Ginecología y Obstetricia; Vol. 14 Núm. 2 (1968); 223-233
2304-5132
2304-5124
reponame:Revista Peruana de Ginecología y Obstetricia
instname:Sociedad Peruana de Obstetricia y Ginecología
instacron:SPOG
instname_str Sociedad Peruana de Obstetricia y Ginecología
instacron_str SPOG
institution SPOG
reponame_str Revista Peruana de Ginecología y Obstetricia
collection Revista Peruana de Ginecología y Obstetricia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1868078729323872256
score 13.408945
Capronate use of 17-hydroxy-19-norprogesterone as injectable contraceptive depot.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares